National Academies Press: OpenBook
« Previous: 4. Steps to Improve the Translation and Dissemination of the Results of Clinical Research
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2003. Exploring Challenges, Progress, and New Models for Engaging the Public in the Clinical Research Enterprise: Clinical Research Roundtable Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10757.
×
Page 45
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2003. Exploring Challenges, Progress, and New Models for Engaging the Public in the Clinical Research Enterprise: Clinical Research Roundtable Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10757.
×
Page 46
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2003. Exploring Challenges, Progress, and New Models for Engaging the Public in the Clinical Research Enterprise: Clinical Research Roundtable Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10757.
×
Page 47
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2003. Exploring Challenges, Progress, and New Models for Engaging the Public in the Clinical Research Enterprise: Clinical Research Roundtable Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10757.
×
Page 48
Suggested Citation:"Appendix A: Workshop Agenda." Institute of Medicine. 2003. Exploring Challenges, Progress, and New Models for Engaging the Public in the Clinical Research Enterprise: Clinical Research Roundtable Workshop Summary. Washington, DC: The National Academies Press. doi: 10.17226/10757.
×
Page 49

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Appendixes

Appendix A Workshop Agenda November 5, 2002 The National Academy of Sciences Auditorium Washington, DC 8:45 am Introduction Goals for the Day Queta Bond, Ph.D. Chair, Clinical Research Roundtable President, Burroughs Wellcome Fund Mary Woolley, MA Workshop Chair President, Research!America 9:00 9:50 10:10 10:30 Panel 1: Participant-Centered Clinical Research Moderator Myrl Weinberg, President, The National Health Council Lawrence W. Green, Dr.P.H. Director, Office of Science and Extramural Research Centers for Disease Control and Prevention Marshall H. Chin, M.D., M.P.H. Associate Professor of Medicine University of Chicago Clinical Research Roundtable Discussion Questions from the Audience Break 47 Zelda Tetenbaum Council of Public Representatives National Institutes of Health Jerome Yates, M.D. National Vice President for Research American Cancer Society

48 ENGAGING THE PUBLIC IN THE CLINICAL RESEARCH ENTERPRISE 10:50 Panel 2: Model Collaborations Among Community/Disease Advocates, Researchers, and Sponsors Moderator Lawrence W. Green, Dr.P.H. Director, Office of Science and Extramural Research, CDC Kenneth Olden, Ph.D. Director National Institute of Environmental Health Science National Institutes of Health Kenneth A. Bertram, M.D., Ph.D., F.A.C.P. Colonel, U.S. Army Medical Corps Director Congressionally Directed Medical Research Programs 11:30 Clinical Research Roundtable Discussion 11:50 Questions from the Audience 12: 10 Lunch Fran Visco President National Breast Cancer Coalition Jennifer Bryson Director, Corporate Affairs Genentech, Inc. Leslie Ford, M.D. Associate Director for Clinical Research Division of Cancer Prevention National Cancer Institute 1:00 pm Panel 3: Increasing the Role of the Public in Research Oversight Moderator Queta Bond, Ph.D. President, Burroughs Wellcome Fund Chair, Clinical Research Roundtable Daniel Federman, M.D. Dean for Alumni Relations and Clinical Teaching Harvard University Chair, IOM Committee on Assessing the System for Protecting Human Research Participants Greg Koski, M.D. Director Office for Human Research Protections DHHS 2:00 Clinical Research Roundtable Discussion 2:30 Questions from the Audience Marjorie Speers, Ph.D. Executive Director Association for the Accreditation of Human Research Protection Programs Nancy Dubler, ID Division of Bioethics Montefiore Medical Center Albert Einstein College of Medicine Liaison, IOM Committee on Assessing the System for Protecting Human Research Participants Angela Bowen, M.D. President Western IRB

APPENDIX A 3:00 Panel 4: Steps to Improve the Translation and Dissemination of the Results of Clinical Research John W. Walsh President and CEO Alpha-1 Foundation Stephen Katz, M.D., Ph.D. Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases 3:50 4:10 4:30 4:45 5:15 49 Moderator Nancy Sung, Ph.D. Program Officer, Burroughs Wellcome Fund Barry Wolcott, M.D. Senior Vice President Clinical Services WebMD Health Clinical Research Roundtable Discussion Questions from the Audience Break NIH Perspective: Priorities for Engaging the Public in the Clinical Research Enterprise Elias Zerhouni, M.D. Director National Institutes of Health Department of Health and Human Services Clinical Research Roundtable Discussion Adjourn to Reception

Next: Appendix B: Speaker Biographies »
Exploring Challenges, Progress, and New Models for Engaging the Public in the Clinical Research Enterprise: Clinical Research Roundtable Workshop Summary Get This Book
×
Buy Paperback | $29.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

This report is a summary of a workshop focused on exploring the role of the public in the Clinical Research Enterprise. The Clinical Research Enterprise depends upon practitioners, policy makers, and others for participation in trials, ethical review of research, and continued support of research funding. However, the role of the public has expanded beyond this traditional model as consumers have begun to demand a role in the formulation of the research agenda and in the design, review, and pursuit of research. This report identifies four major challenges to the Clinical Research Enterprise: enhancing public participation in clinical research, which includes making the system safer and faster; developing the necessary information systems that are needed to make the clinical research enterprise a coordinated and seamless whole; fostering an adequately trained workforce; and ensuring adequate funding for clinical research. In addition, the report identifies two translational blocks--from basic science into clinical practice and from the clinical identification of things that work into broader application to improve medical care and the public's health. This workshop summary addresses the contribution of the public to overcoming these obstacles.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!